dear Rabbit owners,
I am the General director of FILAVIE Laboratory.
The VMD issued on their website on the 12th of July 2018 a recall for FILAVAC K C+V. This recall was issued after FILAVIE informed the VMD about an incident during transportation leading to incorrect storage requirements of a specific shipment of FILAVAC VHD K C+V. This problem being identified BEFORE the affected products were delivered to UK wholesalers. The defective products were sent back to FILAVIE and destroyed.
The affected shipment contained products from batches 060K80412C1A-UK1-2 and 060K80412A1C-UK1-2. The remaining FILAVAC VHD K C+V in stock at FILAVIE (notably from batch number 060K80412C1A-UK-1-2) that were not part of this shipment, have been delivered normally to UK, without incident.
All the FILAVAC VHD K C+V vaccines currently available on the UK market, as all those that have been used previously, meet the quality standards in accordance with the marketing authorization, and can be used with confidence.
We attach great importance to the quality of our products, from production to transportation. We are sincerely sorry for all the inconveniences that may been caused by this incident
We thank our customers for their trust in FILAVAC VHD K C+V that has helped to save many rabbits lives in the UK and will proudly continue to do so.
Thomas PAVIE
General Director
If you want confirmation of this information, please send an email to :
contact.filavie@filavie.com